• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . Challenges in interpreting cytokine data in COVID-19 affect patient care and management

tetano

Editor, Senior Moderator
PLoS Biol


. 2021 Aug 6;19(8):e3001373.
doi: 10.1371/journal.pbio.3001373. Online ahead of print.
Challenges in interpreting cytokine data in COVID-19 affect patient care and management


Stephen Y Wang[SUP] 1 [/SUP], Takehiro Takahashi[SUP] 2 [/SUP], Alexander B Pine[SUP] 3 4 [/SUP], William E Damsky[SUP] 5 [/SUP], Michael Simonov[SUP] 1 [/SUP], Yanhua Zhang[SUP] 6 [/SUP], Elizabeth Kieras[SUP] 6 [/SUP], Christina C Price[SUP] 7 [/SUP], Brett A King[SUP] 5 [/SUP], Mark D Siegel[SUP] 8 [/SUP], Gary V Desir[SUP] 1 [/SUP], Alfred I Lee[SUP] 3 [/SUP], Akiko Iwasaki[SUP] 2 9 [/SUP], Hyung J Chun[SUP] 1 10 9 [/SUP]



Affiliations

Abstract

Challenges in using cytokine data are limiting Coronavirus Disease 2019 (COVID-19) patient management and comparison among different disease contexts. We suggest mitigation strategies to improve the accuracy of cytokine data, as we learn from experience gained during the COVID-19 pandemic.
 
Back
Top Bottom